Based on the future drug delivery vehicle, a drug in nanoformulation based on targeted drug delivery for
effective treatment of cancer is developed. The drug is a Nano formulation consisting of a Nanocarrier, Cancer
specific receptor or general receptor, Sensing material to identify if the cell is normal, malignant or benign,
Substance to indicate the amount of uptake of the nanomaterial by the cell for the staging of cancer, a drug
wrapped in a charged molecule, stabilizing and binding agent.When an external electrical potential is applied to
the solution containing

Nano silver drug delivery
The mixture of stabilizing or binding agent, drug, cancer specific receptor or general receptor, sensing material,
the binding agent loses its negative charge, which causes the nano formulation to disintegrate, releasing the
drugs. The amount of drug delivered and the timing of the dose can be precisely controlled by turning the
voltage on and off. The electrical signal can be remotely administered (for example, by a physician) using radio
signals or other techniques that have already been developed for other biomedical devices. The formulation can
carry discrete packets of drugs that can be released separately, which could be especially beneficial for

Nano silver drug delivery is a most promising field for generating new applications in medicine. However, only
few nanoproducts are currently in use for medical purposes. Nanotechnology has the potential to revolutionize
cancer diagnosis and therapy. Advances in protein engineering and materials science have contributed to novel
nanoscale targeting approaches that may bring new hope to cancer patients.Nanotechnology is the design,
characterization, production and applications of structures, devices and systems by controlling shape and size at
the nanometer scale. Nanometer-sized particles offer novel structural, optical and electronic properties that are
not attainable with individual molecules or bulk solids.

Nano silver based targeted drug delivery for treatment of cancer
Nano silver drug delivery are of great scientific interest as they are effectively a bridge between bulk materials
and atomic or molecular structure. Advances in nanomedicine can be made by engineering nanoparticles that
are capable of targeted delivery of drugs. Drug delivery is the method or process of administering a
pharmaceutical compound to achieve a therapeutic effect in humans and animals.Drug delivery technologies
modify drug release profile, absorption, distribution and elimination for the benefit of improving product
efficacy and safety, as well as patient convenience and compliance.Current efforts in the area of drug delivery
include the development of targeted delivery in which the drug is only active in the target area of the body (for
example, in cancerous tissues) and sustained release formulations in which the drug is released over a period of
time in a controlled manner from a formulation Several therapeutic nanocarriers have been approved for clinical
use. Nanocarriers can offer many advantages over free drugs.

Nano silver drug delivery there are only a few clinically approved nanocarriers that incorporate molecules to
selectively bind and target cancer cells. In recent years, metallic nanoparticles have drawn a lot of attention due
to their unusual physical and chemical properties, which largely differ from their bulk properties. Among all
metals, silver has the highest electrical and thermal conductivity. Our present work proposes a drug in
nanoformulationbased on targeted drug delivery for effective treatment of cancer. The nanoformulation has a
Nanocarrier Conjugation of Nano particles with PEG (Pegylation favor the pharmacokinetics of the these nano
formulations prolonging the circulation periods that grant a proper time frame for the nano particles to be
accumulated in the tumor micro environment although PEG is the most effective method to reduce protein
adsorption invivo and to avoid the RES system clearance). Cancer specific receptor or general receptor.
Nano silver drug delivery material for to identify if the cell is normal, malignant or benign. Substance to
indicate the amount of uptake of the nanomaterial by the cell for stagingthe cancer.f.A drug, pemetrexed which
is an FDA approved drug in the treatment of malignant Pleural Mesothelioma, a type of tumor of the lining of
the lung. In combination with other drugswhose disease is unrespectable orwho are otherwise candidates for
curative surgery. A stabilizing and binding agent.

We invite you to contact us for Nano silver drug delivery information about our company and our capabilities.
If you want to buy nanomaterials or discuss Oxide Nanoparticles,you can mail us at

Leave a Reply